Supply Chain

Via its supply chain network, drug wholesaler has helped deliver more than 75 million vaccines

Marken/UPS, LifeScience Logistics and Packaging Technology Group are among the latest contenders

Previous merger earns clinical research company $235 million as it looks to advance patient enrollment

Using AI and data engineering insight, purchase offers customers potential to shorten clinical trials and accelerate time to commercialization

Pace of production plays a major role, says study

Collaboration centers around providing assistance to multiple links in the clinical trial chain, from participants to providers

The pressure is on for stakeholders to continue pioneering novel engineering designs, insulation options and advanced monitoring and data analytics tools—to meet the complex demands of today’s temperature-controlled products while keeping costs low

A conversation with Volker Kirchner, director, temperature control solutions, World Courier

Pharma’s prime chance to reduce carbon emissions from supply chain

The steps pharma manufacturers can take to mitigate transportation costs amid Covid’s supply-chain crunch

Polish facility will be based on GDP and ISO practices

UK location offers close proximity to London Heathrow Airport

Side effects were consistent with 16-25 age group

Both Comirnaty, Spikevax jabs had previously been authorized for use under Interim Order

Deal is dependent on FDA approval of Phathom’s vonoprazan compound

Acquisition expected to help provide customers with a quicker clinical trial recruitment process

Five-year, nearly $90 million deal revolves around bulk drug substance formulation for Providence’s future shot

FDA’s recommended guidance is for a system that ‘does not exist, cannot be built by 2023, and poses unacceptable security and compliance risks,’ says alliance

Biotech firm to file regulatory dossier with officials around the world

Collaboration earns Adaptimmune an initial payday of $150 million

Supply deal with Takeda to begin distribution in early 2022, pending shot approval

Drug maker to supply European Union with 60 million doses by end of Q3

Company’s prospective malaria and tuberculosis doses will be developed in Rwanda, Senegal

Meeting future expectations in pharmaceutical sustainability a key component of shipping collaboration

Project will center on equipment and technology improvements, says UK R&D and manufacturing accelerator